Get started
Author

Dai Chihara

Observed name: Chihara Dai
OpenAlex ID: A5111218582
Large B cell lymphoma microenvironment archetype profiles
2025 · Xubin Li, Kartik Singhal, et al. · Cancer Cell · 35
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
2024 · Jillian R Gunther, Jie Xu, et al. · The Lancet Haematology · 30
Multi-modal spatial characterization of tumor immune microenvironments identifies targetable inflammatory niches in diffuse large B cell lymphoma
2025 · Yibo Dai, Atish Kizhakeyil, et al. · Nature Genetics · 25
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy
2025 · James P. Long, Rishab Prakash, et al. · JAMA Network Open · 13
PDF
Phase 2 trial of epcoritamab in combination with rituximab-mini CVP for older unfit/frail or anthracycline-ineligible adult patients with newly diagnosed diffuse large B-cell lymphoma: Interim futility analysis.
2026 · Dai Chihara, Ayushi Chauhan, et al. · Journal of Clinical Oncology · 1
Ciltacabtagene Autoleucel Immune Effector Cell Enteritis/Colitis Is Driven By Persistent Clonal CAR+ T-Cells.
2026 · Mark P. Hamilton, Sharlene Dong, et al. · Transplantation and Cellular Therapy · 1
CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab
2024 · Raphael Steiner, Allison M. Bock, et al. · Blood · 1
Germline Predisposition to Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) after CAR T Cell Therapy for Lymphoma and Myeloma
2026 · Anath Lionel, Cao Cuong Le, et al. · International Journal of Cancer Care and Delivery
PDF
Survival Outcomes and Treatment Responses in Patients with Dual B-Cell and T-Cell Lymphoma Diagnoses
2026 · Sami Khaznadar, Chiara Hummel, et al. · International Journal of Cancer Care and Delivery
PDF
Epidemiologic Characterization of Risk Factors in Patients with Dual Diagnosis of B-cell and T-cell Lymphomas
2026 · Sami S. Khaznadar, Zachary E. Hunzeker, et al. · International Journal of Cancer Care and Delivery
PDF
Patterns of care, outcomes, and prognostics for transformed follicular lymphoma in the rituximab era
2026 · Jonathan R. Day, Melissa C. Larson, et al. · Haematologica
PDF
TCL-979: Epidemiologic Assessment of Risk Factors for Dual Diagnoses of B-Cell and T-Cell Lymphomas
2026 · Chiara A Hummel, Sami S Khaznadar, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: TCL-977: Survival Outcomes in Patients With Dual B-Cell and T-Cell Lymphoma Diagnoses
2026 · Sami S Khaznadar, Chiara A Hummel, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: TCL-979: Epidemiologic Assessment of Risk Factors for Dual Diagnoses of B-Cell and T-Cell Lymphomas
2026 · Chiara A Hummel, Sami S Khaznadar, et al. · Clinical Lymphoma Myeloma & Leukemia
TCL-977: Survival Outcomes in Patients With Dual B-Cell and T-Cell Lymphoma Diagnoses
2026 · Sami S Khaznadar, Chiara A Hummel, et al. · Clinical Lymphoma Myeloma & Leukemia
Safety of concurrent radiation therapy with the antibody-drug conjugate polatuzumab vedotin in relapsed or refractory aggressive B-cell lymphomas
2026 · Sophie T. Melancon, Ethan B. Wang, et al. · Practical Radiation Oncology
Abstract A041: Prognostic significance of post-CAR-T macrocytosis in large B-cell lymphoma
2026 · Shady I. Tantawy, Mark Hamilton, et al. · Blood Cancer Discovery
Abstract A017: A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma
2026 · Haopeng Yang, Kotaro Arita, et al. · Blood Cancer Discovery
Abstract A037: FLIPI24 stratifies outcomes in follicular lymphoma treated with R2-based therapy: A pooled MD Anderson trial cohort
2026 · Dai Chihara, Zhiping Luo, et al. · Blood Cancer Discovery
Abstract A049: Spatially resolved microenvironment profiling reveals distinct follicular lymphoma archetypes
2026 · Yoshiaki Abe, Bijal Thakkar, et al. · Blood Cancer Discovery
Phase 2 trial of lisocabtagene maraleucel for minimal residual disease in patients with large B-cell lymphoma.
2026 · Dai Chihara, Ruitao Lin, et al. · Journal of Clinical Oncology
An APP-led intake model to expedite diagnostic workup for patients with suspected lymphoma.
2026 · Erin Taylor, Jason Westin, et al. · Journal of Clinical Oncology
Pre-infusion plasma proteomics identifies an endothelial–immune priming signature predictive of severe cytokine release syndrome and neurotoxicity following CAR T-cell therapy in relapsed/refractory lymphoma
2026 · Ehsan Irajizad, Johannes F. Fahrmann, et al. · medRxiv
PDF
Consolidation with Loncastuximab Tesirine for Large B-cell Lymphoma Patients in Partial Response after CART: Planned Interim Futility Analysis of a Phase II Trial
2026 · Mark P. Hamilton, Ajlan Al Zaki, et al. · Transplantation and Cellular Therapy
Baseline Physical Function Predicts Toxicity Outcomes after Chimeric Antigen Receptor T-cell Therapy in Non-Hodgkin Lymphoma
2026 · Rahul Shah, Zhiping Luo, et al. · Transplantation and Cellular Therapy
Works count: 30
Citation count: 106
H-index: 4
I10-index: 4
Year
Topic
Type